Search Results 841-850 of 21426 for anti-TNF drugs

  1. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

    Drugs used in chemotherapy ... TNF] agents) within 2 weeks prior to cycle 1, day 1: ... A stable regimen of highly active anti-retroviral therapy (HAART); ...

  2. Lamotrigine (Oral Route) Proper Use - Mayo Clinic

    Keep using all of your seizure medicines unless your doctor tells you to stop. Dosing. The dose of this medicine will be different for different patients.

  3. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    History of systemic anti-cancer therapy (e.g., chemotherapy, targeted therapy) ... therapy for treatment of metastatic disease. ... TNF] factor agents) within 14 ...

  4. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD - Mayo Clinic News Network

    In a new study, Mayo Clinic in Florida researchers and collaborators have found that the antiviral medication Paxlovid reduces the risk of hospitalization ...

  5. Immune Globulin (Intramuscular Route, Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Immune globulin injection belongs to a group of medicines known as immunizing agents. ... Drugs & Supplements; Immune Globulin (Intramuscular Route, Intravenous ...

  6. Ketoconazole (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Extina; Ketodan Kit; Kuric; Nizoral; Nizoral ...

  7. Buprenorphine/Naloxone (Oromucosal Route, Sublingual Route) Description and Brand Names - Mayo Clinic

    Buprenorphine and naloxone buccal film, sublingual film, or sublingual tablet is used for induction and maintenance treatment of opioid (narcotic) dependence.

  8. Ertugliflozin And Metformin (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Reslizumab (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218) - Mayo Clinic

    Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or ...